• Cholesterol Sensing by Frizzled5 Drives Wnt/β-Catenin in PDA

  2026-04-22

  This study uncovers a novel mechanism whereby Frizzled5 (Fzd5) directly binds cholesterol, enabling its palmitoylation, maturation, and plasma membrane trafficking in pancreatic cancer. The findings reveal how aberrant cholesterol metabolism converges with Wnt/β-catenin signaling to support tumor growth, offering mechanistic insight and highlighting new therapeutic targets.

• EdU Imaging Kits (Cy3): Precision S-Phase DNA Synthesis Anal

  2026-04-22

  EdU Imaging Kits (Cy3) empower researchers with high-sensitivity, antibody-free detection of cell proliferation for advanced cancer and drug response studies. Their click chemistry workflow preserves cell integrity and streamlines assay optimization, offering reproducibility even in challenging organoid co-culture systems.

• BV6 IAP Antagonist: Applied Workflows and Troubleshooting In

  2026-04-21

  BV6 is a selective IAP antagonist enabling precise apoptosis induction and radiosensitization in cancer research. This article details practical workflows, troubleshooting tips, and translational guidance for maximizing BV6's experimental value, directly informed by peer-reviewed and scenario-driven evidence.

• Concanamycin A: Precision V-type H+-ATPase Inhibitor Workflo

  2026-04-21

  Concanamycin A from APExBIO empowers cancer biology research with robust, reproducible disruption of V-ATPase-mediated endosomal acidification and apoptosis. This guide translates bench-proven protocols and troubleshooting into actionable insights, enabling researchers to optimize tumor cell invasion studies and mechanistic pathway interrogation.

• Ertugliflozin (PF-04971729): Optimizing SGLT2 Inhibitor Work

  2026-04-20

  Ertugliflozin (PF-04971729) elevates diabetes mellitus research with unmatched SGLT2 selectivity and robust protocol versatility. This article delivers actionable guidance for designing, troubleshooting, and advancing renal glucose transport studies using APExBIO’s high-purity compound.

• Sumatriptan Succinate: Metabolic Insights for 5-HT1B/1D Rese

  2026-04-20

  Explore how Sumatriptan Succinate advances 5-HT1 receptor agonist studies with new metabolic insights and anti-inflammatory applications. This article reveals what sets APExBIO's Sumatriptan apart in migraine research compound workflows.

• CB-5083: Precision p97 Inhibitor for Protein Homeostasis Dis

  2026-04-19

  CB-5083 stands out as a potent, selective p97 inhibitor, enabling researchers to dissect protein degradation pathways and induce targeted cancer cell apoptosis. Its nanomolar efficacy and robust in vivo performance make it a premier tool for translational oncology and protein homeostasis disruption studies.

• Exo1 (methyl 2-(4-fluorobenzamido)benzoate): Precision Inhib

  2026-04-18

  Exo1 offers researchers a mechanistically distinct approach to membrane trafficking inhibition, enabling acute disruption of ER-to-Golgi transport without off-target effects on the trans-Golgi network. This article details optimized workflows, troubleshooting guidance, and actionable insights for leveraging Exo1 in advanced exocytosis assays and extracellular vesicle research.

• Angiotensin III: Applied Protocols for RAAS & Signaling Rese

  2026-04-17

  Angiotensin III (human, mouse) enables precise modeling of RAAS-mediated pressor activity and aldosterone secretion, with validated workflows supporting both cardiovascular and neuroendocrine research. This guide translates recent mechanistic insights and peer-reviewed data into actionable experimental protocols and troubleshooting strategies, ensuring reproducibility and flexibility in complex assay environments.

• Proteoform-Specific Drug Interactions in Native Membranes

  2026-04-16

  This study establishes a mass spectrometry-based workflow to identify and characterize proteoform-specific ligand interactions within native cell membranes. By directly analyzing membrane protein complexes and their post-translational modifications, the research illuminates the nuanced off-target effects of PDE5 inhibitors like Vardenafil on visual signaling proteins, guiding more precise drug development.

• 2X HyperFusion High-Fidelity Master Mix: Precision for Cloni

  2026-04-15

  2X HyperFusion™ High-Fidelity Master Mix streamlines high-accuracy DNA amplification in cloning and gene-editing workflows, offering ultra-low error rates and robust blunt-end product generation. Its advanced proofreading polymerase and optimized master mix formulation set a new standard for reproducibility and speed in PCR-dependent translational research.

• Patient-Derived Gastric Cancer Assembloids Reveal Drug Respo

  2026-04-14

  This study introduces a patient-specific gastric cancer assembloid model that integrates matched tumor organoids and stromal cell subpopulations, closely mimicking the heterogeneity and microenvironment of primary tumors. The findings highlight how stromal components shape gene expression and drug sensitivity, offering a more physiologically relevant platform for investigating tumor biology and optimizing targeted therapy strategies.

• 7ACC2: Unraveling MCT1 Inhibition for Tumor Microenvironment

  2026-04-13

  Explore how 7ACC2, a potent monocarboxylate transporter 1 inhibitor, uniquely empowers cancer metabolism research by disrupting lactate dynamics and illuminating new immunometabolic assay strategies. This article delivers distinct, practical insights for advanced experimental design.

• HyperScribe Co-transcription mRNA Synthesis Kit Plus: Mechan

  2026-04-13

  The HyperScribe Co-transcription mRNA Synthesis Kit Plus enables efficient ARCA-capped mRNA synthesis with integrated polyadenylation, crucial for advanced RNA vaccine development and in vitro translation assays. Evidence supports its superior yield and translational efficiency compared to prior workflows. This article details its mechanism, applications, and validated benchmarks.

• Cdk5 Downregulation Mitigates Neuronal Ferroptosis via AMPK

  2026-04-12

  This study demonstrates that inhibiting Cdk5 activity reverses ferroptotic neuronal death in the hippocampus after ischemic injury, primarily by modulating the AMPK pathway and suppressing pro-inflammatory microglial polarization. These findings clarify mechanistic links between iron-dependent cell death, neuroinflammation, and kinase signaling, offering actionable targets for neuroprotection in stroke.

15012 records 1/1001 page Next 12345 下5页 Last page